Asia Pacific Facial Injectable Market Size & Outlook
Asia Pacific facial injectable market, 2018-2030 (US$M)
Related Markets
Asia Pacific facial injectable market highlights
- The Asia Pacific facial injectable market generated a revenue of USD 2,666.5 million in 2023.
- The market is expected to grow at a CAGR of 12% from 2024 to 2030.
- In terms of segment, botulinum toxin type a was the largest revenue generating product in 2023.
- HA is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 2,666.5 million |
| Market revenue in 2030 | USD 5,897.0 million |
| Growth rate | 12% (CAGR from 2023 to 2030) |
| Largest segment | Botulinum toxin type a |
| Fastest growing segment | HA |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Collagen, Botulinum Toxin Type A, HA, CaHA, Polymer Fillers |
| Key market players worldwide | Ipsen SA, AbbVie Inc, Medytox, Revance Therapeutics Inc, Galderma Group AG Registered Shares, Sinclair Pharma plc, Merz Pharma |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 22.4% of the global facial injectable market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,897.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Facial Injectable Market Scope
Facial Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific facial injectable market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to facial injectable market will help companies and investors design strategic landscapes.
Botulinum toxin type a was the largest segment with a revenue share of 55.33% in 2023. Horizon Databook has segmented the Asia Pacific facial injectable market based on collagen, botulinum toxin type a, ha, caha, polymer fillers covering the revenue growth of each sub-segment from 2018 to 2030.
China, India, and Japan are developing economies and key revenue contributors to the facial injectables market in the region. With rapidly developing economies, the Asia Pacific facial injectables market is expected to witness rapid growth.
This can be attributed to the growing medical tourism industry, especially in Southeast Asian countries. According to the ISAPS 2022 report, 29% of the patients undergoing aesthetic treatment in Thailand were foreign nationals.
The growing preference among foreign nationals to undergo treatments in Thailand can be attributed to the availability of advanced techniques and cost-effective treatment options. Furthermore, the Asia Pacific facial injectables market is expected to grow at a CAGR of 11.03% over the forecast period due to the presence of growth opportunities in this region, especially in India, Japan, and China.
Reasons to subscribe to Asia Pacific facial injectable market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific facial injectable market databook
-
Our clientele includes a mix of facial injectable market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific facial injectable market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific facial injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific facial injectable market size, by country, 2018-2030 (US$M)
Asia Pacific Facial Injectable Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
